Coming October 29: SITC releases its late-breaking abstract titles. We’ll add their presenting authors’ institutions to this guide once they’re out.

IDIBAPS at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

IDIBAPS brings 2 presentations to SITC 2026 in Phoenix. Its program centres on finding T cells and T cell receptors that recognise tumors, for use in cell therapy. One study identifies receptors against NY-ESO-1 for CD4 T cell therapy, and another uses PD-1 and CD39 to pick out tumor-specific cells for tumor-infiltrating lymphocyte therapy.

Organization	SITC 2026 Attendance
IDIBAPS Barcelona, Spain
idibaps.org Universities & research institutes Biomedical research institute affiliated with Hospital Clínic de Barcelona.	Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Discovery and functional validation of HLA class II-restricted NY-ESO-1-specific T cell receptors for CD4+ T cell therapy Exhibition Halls 4-6 · Poster 273 Cell therapy · Biomarkers Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm PD-1high CD39+ population as a source of tumor-specific T-cells for the development of Adoptive Cell Therapies based on Tumor Infiltrating Lymphocytes Exhibition Halls 4-6 · Poster 350 Cell therapy

Organization

SITC 2026 Attendance

IDIBAPS

Barcelona, Spain

idibaps.org

Universities & research institutes

Biomedical research institute affiliated with Hospital Clínic de Barcelona.

Poster

Fri Nov 6
12:15–1:45pm
5:30–7pm

Discovery and functional validation of HLA class II-restricted NY-ESO-1-specific T cell receptors for CD4+ T cell therapy

Exhibition Halls 4-6 · Poster 273

Cell therapy · Biomarkers